Catalog Advanced Search
176 Results
-
Includes a Live Web Event on 11/18/2025 at 10:00 AM (PST)
By connecting science with culture and care, this webinar underscores how equitable approaches can transform outreach into meaningful, lasting confidence in vaccination.
Description:
Date: Tuesday, November 18, 2025
Time: 1:00 - 2:00 pm ET / 10:00 - 11:00 am PT
Building trust in vaccines requires more than sharing facts. It calls for understanding the human experiences that shape decision-making. This webinar explores the psychological, cultural, and linguistic influences that contribute to hesitancy, highlighting the role of empathy and respect in effective dialogue. Practical strategies grounded in patient-centered communication will be examined alongside collaborative models that bring healthcare teams and community partners together. By connecting science with culture and care, this webinar underscores how equitable approaches can transform outreach into meaningful, lasting confidence in vaccination.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Identify key psychological, cultural, linguistic and systemic factors that contribute to vaccine hesitancy;
- Apply patient-centered communication strategies to address misinformation and to build vaccine trust;
- Evaluate collaborative care models and cross-functional strategies that promote vaccine equity and strengthen community-level outreach efforts.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
This activity is supported by an independent medical education grant from Sanofi US.
Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Institute sponsors.
Cindy Hou, DO, MA, MBA, FACOI, FACP, FIDSA
Infection Control Officer and Medical Director of Research
Jefferson Health – New Jersey
Cindy Hou, DO, MA, MBA, CIC, CPHQ, CPPS, FACOI, FACP, FIDSA, FAPIC, is the Infection Control Officer and Medical Director of Research for Jefferson Health – New Jersey and an Infectious Diseases specialist. She has expertise in sepsis, antibiotic stewardship, infection control, patient safety, clinical quality, equity, and language access.
Dr. Hou is the Chief Medical Officer of Sepsis Alliance and a member of its Board of Directors. She earned her M.B.A. and M.A. from Boston University, a D.O. from the University of New England College of Osteopathic Medicine, and her B.S. from Yale University.
Dr. Hou is the principal investigator for an Office of Minority Health grant to reduce inequities in those with limited English proficiency. She is the co-editor of the book, “COVID-19 Viral Sepsis: Impact on Disparities, Disability, and Health Outcomes.”
Dr. Hou has a Certification in Infection Prevention and Control, is a Certified Professional in Healthcare Quality, and is a Certified Professional in Patient Safety. Dr. Hou is a Fellow of the American College of Osteopathic Internists, American College of Physicians, Infectious Diseases Society of America, and Association for Professionals in Infection Control and Epidemiology.
Accreditation Statements
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
Financial Relationship Disclosures:
Cindy Hou disclosed the following relevant financial relationships:
- Advisory board member for Abbott
- Panelist for Sanofi
All relevant financial relationships have been mitigated.
All other individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Includes a Live Web Event on 11/06/2025 at 11:00 AM (PST)
By connecting science with culture and care, this webinar underscores how equitable approaches can transform outreach into meaningful, lasting confidence in vaccination.
Description:
Date: Thursday, November 6, 2025
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
Sepsis remains a critical public health concern, often stemming from common bacterial infections that can often be prevented. This informative webinar explores the essential role vaccines play in reducing the prevalence and burden of bacterial sepsis. By examining the most common bacterial causes and the science behind vaccine development, this presentation highlights how immunization strategies disrupt the pathways that lead to severe infection. Attendees will also gain insight into the rigorous processes that ensure vaccine safety and effectiveness in the fight against life-threatening illness, as well as key factors influencing vaccine confidence and hesitancy.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe why vaccines are important for preventing sepsis
- Identify the major bacterial pathogens causing sepsis
- Review principles of vaccinology, bacterial vaccine development, and safety monitoring
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
This activity is supported by an independent medical education grant from Sanofi US.
Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Institute sponsors.
Robert Donald, PhD
Retired Research Microbiologist
Robert Donald, PhD, is a research microbiologist with broad experience in bacterial, viral, and eukaryotic parasitic systems. While a senior research fellow at Merck, he contributed to drug discovery programs to identify new antibiotics to prevent S. aureus, antifungal, and parasitic infections. More recently, while a senior director at Pfizer, he led a preclinical vaccine development program targeting Klebsiella and E. coli invasive infections. Prior to this, he was also the scientific lead for preclinical programs advancing C. difficile, Enterococcus, and Group B Streptococcus vaccines, while managing supporting molecular biology and assay development teams.
Robert became motivated to assist with Sepsis Alliance’s mission due to his “firsthand” experience with the invasive bacterial pathogens that cause sepsis, and familiarity with emerging therapeutic or vaccine-based strategies currently under development in academia and biotech/pharma sectors. Now retired from commercial R&D, he seeks to contribute scientifically through advising and educating. In addition to serving on the Sepsis Alliance Advisory Board, he is consultant to Carb-X, whose mission is to fund research to develop new therapies and vaccines to address antimicrobial drug resistance.
Robert is a graduate of the University of California Santa Cruz, and did post-doctoral research at the University of California Berkeley and the University of Pennsylvania.
Accreditation Statements
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
Financial Relationship Disclosures:
Robert Donald disclosed the following relevant financial relationship:
- Former employee, Pfizer
All relevant financial relationships have been mitigated.
All other individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Includes a Live Web Event on 10/14/2025 at 12:00 PM (PDT)
Content provided by Vantive (No CE credits offered)
Webinar Description:
Join Vantive for an in-depth exploration of the TIGRIS trial. Jonathan Eaton, MD, will walk attendees through a patient journey, exploring the challenges of managing patients with endotoxic septic shock, emerging therapies, and how Dr. Eaton’s involvement in the TIGRIS trial has impacted his bedside practice. You do not want to miss this sponsored webinar on one of today’s hottest topics in the management of sepsis.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Vantive for this sponsored webinar.
Jonathan Eaton, MD
Title: Assistant Professor of Internal Medicine; Program Director of Critical Care Medicine Fellowship; Assistant Director of Extracorporeal Life Support Program; Director of ECMO Transport
LSU Health Shreveport
Jonathan Eaton, MD, serves as a Critical Care Specialist at LSU Health Shreveport, where he contributes to the Extracorporeal Life Support Program, extracorporeal membrane oxygenation (ECMO), continuous renal replacement therapies (CRRT), plasma exchange, and sepsis management.
Dr. Eaton received his medical degree from the American University of the Caribbean and completed his Internal Medicine training at LSU Health Shreveport. He completed his fellowship training in Critical Care Medicine at LSU Health Shreveport.
-
Annual, virtual conference covering sepsis-related topics and offering RN CE Contact Hours
Description
Sepsis Alliance Summit returns for a 6th year this September! This free, virtual 2-day conference features insightful, innovative presentations from a diverse group of experts, including clinicians, researchers, innovators, and key leaders in the field.
FREE Nursing CE Credits Offered!
Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve sepsis care. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.
Conference Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:
Agenda
September 24, 2025
Time (ET) Session Title Presenter 10:00-10:10 Opening Remarks Carl Flatley
Founder, Sepsis Alliance10:10-10:40 Wife and Death: A Lady Glaucomflecken Keynote Kristin Flanary, MA
International Speaker, Podcaster, Glaucomflecken10:45-11:15 More Info to Come 11:20-11:50 Baxter Sponsored Session: Fluids, Sepsis, and Mortality: Past, Present, and Future Angela Craig, MS, APN, CCNS, CCRN
Medical Science Liaison - Medical Affairs, Baxter
Lisa M Soltis, MSN, APRN, PCCN, CCRN-CSC-CMC, CES-A, CCNS, FCNS, FCCM,
Sr. ECMO Clinical Support Specialist, Heart and Lung Division, Fresenius Medical Care11:50-12:05 Break 12:05-1:05 Before and After Sepsis: Opportunities for Change David Carlbom, MD
Associate Professor of Medicine, Pulmonary Critical Care & Sleep Medicine,
University of Washington School of Medicine
Fatima Sheikh, MSc, PhD(c)
PhD Candidate in the Health Research Methodology Program,
McMaster University
Hailey Bain
Sepsis Survivor, Patient Partner,
Sepsis Canada
Catherine Hough, MD, MSc
Professor and Chair of the Department of Medicine
Oregon Health & Science University
Kristina Rudd, MD, MPH
Assistant Professor in the Department of Critical Care Medicine
University of Pittsburgh
Stephanie Parks Taylor, MD, MS
Professor of Medicine, Department of Internal Medicine,
University of Michigan
John Boyd, MD
Intensivist and Investigator & Investigator at the Institute for Heart + Lung Health
Providence Hearth and Lung Institute at St. Paul’s Hospital1:10-1:25 More Info to Come 1:25-1:40 More Info to Come 1:45-2:15 Diasorin Molecular Sponsored Session: Unmasking the Silent Threat: Rapid Molecular Diagnostics for Fungal Sepsis and Detection of Candida auris Siu Kei (Jacky) Chow, Ph.D., D(ABMM)
Clinical Laboratory Director, Multicare Health System Washington State2:15-2:30 Break 2:30-3:00 Strengthening Documentation to Drive SEP-1 Compliance and Quality Performance (CE Session) Alexis Wells, MSN, RN, CCDS, LSSYB
Associate Director of Education and Quality,
Emory Healthcare
Stacia Gandee, RHIA, CCS, CDIP, LSSYB
Manager of Clinical Documentation Integrity, JPS Health Network3:05-3:35 Trials and Triumphs from 20 Years of 'Slay Sepsis' at Santa Barbara Cottage Hospital (CE Session) Natalie Achamallah, MD, MA, MS, FCCP
Director of Critical Care Education for Internal Medicine Residency, Santa Barbara Cottage Hospital3:40-3:55 Roche Sponsored Session: Sepsis Detection in Acute Care: How Biomarkers and AI Assist in Diagnosis and Prediction of Adverse Outcomes Robin Carver, RN, MSN, CIC
Vice President, Health System Management, Prenosis, Inc.4:00-4:30 More Info to Come 4:35-4:55 Breaking the Cycle: Managing Sepsis Recovery and Preventing Readmissions (CE Session) Philip Nicotera, MHA, PA-C
Sepsis Program Manager, Lee Health
Scott Liebal, BSN, CCRN
Advanced Application Analyst, Medical Informatics, Lee Health4:55-5:00 Closing Remarks September 25, 2025
Time (ET) Session Title Presenter 10:00-10:15 Opening Remarks 10:15-10:45 Keynote: Pediatric Sepsis from the Perspective of "The Pitt" Sylvia Owusu-Ansah MD, MPH. FAAP
Associate Professor of Pediatrics and Emergency Medicine; Associate Vice Chair of Diversity, Equity, and Inclusion Department of Pediatrics, University of Pittsburgh School of Medicine10:50-11:20 Previously Healthy Patients with Sepsis: Shedding Light on a Unique Cohort and Opportunities for Enhanced Care Rachel K. Hechtman, MD
Clinical Lecturer, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine
University of Michigan11:25-11:55 Abionic Sponsored Session: More Info to Come 11:55-12:10 Break 12:10-12:40 The Paradigm Shift in Diagnostics to Support Earlier Diagnosis of Sepsis and Antibiotic Stewardship in the Emergency Department (CE Session) Larissa May, MD, MSPH, MBA
Professor of Emergency Medicine, University of California Davis12:45-1:15 Hospital-Acquired Sepsis: The Hidden Challenge in Patient Safety (CE Session) Namita Jayaprakash, MB BcH BAO, MRCEM
Associate Medical Director - Quality and Safety, Emergency Medicine Physician Lead - Henry Ford Health Sepsis Program, Henry Ford Health1:20-1:35 Diasorin - Immunodiagnostics Sponsored Session: More Info to Come 1:40-1:55 Flosonics Medical Sonsored Session: What SEP-1 Misses and How Smart Teams Fill the Gaps Jaclyn Bond, MSN-LM, MBA-HM, RN
Former Director of Nursing1:55-2:10 Break 2:10-2:40 Sepsis Subphenotypes: Development, Validation, and Implementation of a Precision Medicine Approach (CE Session) Sivasubramanium (Siva) Bhavani, MD, MS
Assistant Professor of Medicine, Emory School of Medicine2:45-3:15 "Now What?”: Confronting the Chaos After Sepsis Bundle Completion (CE Session) Sarah Vance MSN, RN, CCRN
Critical Care Nurse Educator, Consultant, Speaker, Writer, ISeeUNurse, LLC3:20-3:50 Boston Scientific Sponsored Session: Treating Kidney Stone Patients with Higher Risk for Sepsis Khurshid Ghani, M B ChB, MS, FRCS
Clinical Professor of Urology, University of Michigan3:55-4:40 Sepsis: Advancing Care Through Unique Partnerships and Collaboration (CE Session) Pat Posa RN, BSN, MSA, CCRN-K, FAAN
Quality and Patient Safety Program Manager, UH/CVC, Michigan Medicine
Hallie Prescott, MD, MSc
Associate Professor of Internal Medicine Division of Pulmonary Critical Care, University of Michigan
Amy Milewski, MD, MBA
Vice President and Associate CMO, Clinical Partnerships, Blue Cross Blue Shield of Michigan
Scott Flanders, MD
Chief Clinical Strategy Officer, Michigan Medicine4:40-4:50 Closing Remarks -
Includes a Live Web Event on 09/17/2025 at 11:00 AM (PDT)
Content provided by Beckman Coulter (No CE credits offered)
Webinar Description:
This sponsored presentation will highlight the crucial role of host response in infection and sepsis management for improved patient outcomes. We will explore the clinical utility of novel biomarkers like MeMed BV (bacterial/viral differentiation) and MDW (early sepsis detection) and discuss strategies to integrate these innovations into routine practice, enhancing diagnostic precision and optimizing care.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Beckman Coulter for this sponsored webinar.
Richard Hamilton, MD, MBA, FAAEM, FACEP, FACMT
Professor and Chair, Emergency Medicine
Drexel University College of Medicine
Richard Hamilton, MD, MBA, FAAEM, FACEP, FACMT, is Professor and Chair, Emergency Medicine, Drexel University College of Medicine. He is the Executive Medical Director of Pediatric Emergency Medicine at St Christopher's Hospital for Children. He was formerly the Regional Associate Dean for the Crozer Keystone Campus and EM System Chair of the Crozer Keystone Health System. He is a graduate of the University of Pennsylvania and Hahnemann University College of Medicine. Dr. Hamilton trained at the San Diego Naval Hospital and the Naval Aerospace Medical Institute, completed an EM Residency at the Bronx Municipal Hospital Center / Albert Einstein, and did his Toxicology Fellowship at New York City Poison Control Center / NYU Bellevue.
Dr. Hamilton's research interests include PFAS toxicity, Manganese, water quality, synthetic cannabinoids, MRSA, pharmacology, toxicology, applying game theory to medicine, aerospace medicine, and commercial space travel. He has received awards for his teaching and research and is a widely published author of manuscripts, textbooks, book chapters, and patents.
Dr. Hamilton is a former EM Program Director and has been EM Chair at Drexel University since 2006. He edited the Tarascon Adult Emergency Pocketbook and Tarascon Pocket Pharmacopeia, which was sold in 17 countries and has been translated into Spanish and Japanese. Dr. Hamilton is a Fellow of the American Academy of Emergency Medicine, the American College of Medical Toxicology, the American College of Emergency Physicians, and an Associate Fellow of the Aerospace Medical Association. He is the Past President of the Association of Academic Chairs in Emergency Medicine and the Pennsylvania College of Emergency Physicians. Dr. Hamilton blogs at www.emtoxcast.com and www.thetoxfiles.com.
Peter S. Antkowiak, MD
Vice Chair of Clinical Operations, Department of Emergency Medicine
UMass Medical School - Baystate Health
Dr. Peter Antkowiak is the Vice Chair of Clinical Operations in the Department of Emergency Medicine at Baystate Health. In this role, he oversees a network of five emergency departments that care for over 220,000 patients annually, including Baystate Medical Center, an academic Level 1 Trauma Center with one of the busiest EDs on the east coast and a dedicated pediatric ED. He is the director of the EM Operations & Administrative Fellowship at Baystate. His primary research interests include ED throughput optimization, applications of novel diagnostics and AI in EM, and understanding physician resource-utilization. He also serves as an expert medical consultant for biotech and healthcare AI startups.
Prior to this role, Dr. Antkowiak was Chief of Emergency Medicine at UMass Harrington Healthcare, overseeing two EDs with a combined 40,000+ patient visits per year staffed by Harvard Medical Faculty Physicians. During his five-year tenure as Chief, Dr. Antkowiak recruited and led a team of physicians that significantly enhanced quality and operational metrics while concurrently optimizing practice revenues. Dr. Antkowiak was responsible for developing long-term strategy, managing the practice budget, and led all clinical operations including overseeing physician directors in Ultrasound, Education, EMS, Operations, and Quality/Patient Safety.
Dr. Antkowiak was previously an academic faculty member at Beth Israel Deaconess Medical Center and an instructor at Harvard Medical School. He chaired the Harvard Medical Faculty Physicians EM Program & Faculty Development committee, and led several network initiatives focused on faculty retention, scheduling principles, and community to tertiary care patient transfer processes.
Dr. Antkowiak studied neuroscience and economics at McGill University, he then earned an MD from Albany Medical College. After residency at Maine Medical Center/Tufts University School of Medicine, he completed a fellowship in ED Operations & Administration and an MPH in Healthcare Management & Policy at the Harvard University T.H. Chan School of Public Health.
Melissa Naiman, PhD, EMT-B
Medical Director for Sepsis & Host Response
Beckman Coulter
Melissa Naiman, PhD, EMT-B, is a Medical Director for Beckman Coulter Diagnostics. She trained in chemistry and has a PhD in Public Health with a research interest in technology adoption in healthcare settings. She spent her early career in an academic research center at the University of Illinois that developed medical devices and diagnostics, including identifying novel biomarkers for military health applications. Today she focuses on accelerating innovation in host response-based diagnostic strategies targeting acute infection and sepsis management.
-
Recorded On: 08/26/2025
This webinar explores the groundbreaking international effort to develop a burn-specific framework for early identification, prevention, and management of sepsis.
Description:
Date: August 26, 2025
Time: 2:00 - 3:00 pm ET
Burn-related sepsis presents unique diagnostic and treatment challenges that traditional sepsis protocols fail to address. This webinar explores the groundbreaking international effort to develop a burn-specific framework for early identification, prevention, and management of sepsis. Drawing from expert consensus and the latest evidence, the webinar highlights key distinctions in pathophysiology, the limitations of conventional screening tools, and the development of actionable clinical recommendations designed to improve outcomes in this high-risk population.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Differentiate between the systemic inflammatory response caused by burn injury and true sepsis, using current definitions and diagnostic criteria;
- Identify clinical indicators and evidence-based triggers for initiating sepsis management in burn patients;
- Apply the Surviving Sepsis After Burn Campaign (SSABC) recommendations to guide prevention, diagnosis, and treatment strategies in clinical practice;
- Describe existing protocols for burn sepsis management and identify opportunities for improvement based on SSABC consensus guidelines.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Institute sponsors.
David Greenhalgh, MD, FACS
Professor Emeritus
University of California Davis
David G. Greenhalgh, MD, FACS, was named Chief of Staff for Burn Surgery at the Shriners Hospitals for Children Northern California, and Department of Surgery for the University of California, Davis, School of Medicine in 1997. He retired from the University of California, Davis in 2022 as Professor Emeritus and then retired from Shriners in 2024.
Upon completion of his fellowships in 1989, Dr. Greenhalgh was employed at Shriners Hospitals for Children Cincinnati and the University of Cincinatti. From 2006-2007, Dr. Greenhalgh served as President of the American Burn Association and was President of the International Society for Burn Injuries from 2020-2022. He is past Editor of Burns Open and remains Associate Editor for Journal Burn Care and Research and PLOS.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1 contact hour.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
- Differentiate between the systemic inflammatory response caused by burn injury and true sepsis, using current definitions and diagnostic criteria;
-
Cytovale Sponsored Webinar: Transforming Sepsis Care: A Nurse-Led Revolution at St. Dominic Hospital
Content provided by Cytovale (No CE credits offered)
Webinar Description:
In this sponsored webinar, discover how IntelliSep is helping redefine sepsis care in the ED by providing a fast, objective, and reliable diagnostic solution that supports early decision-making. Learn how the nursing team at St. Dominic Hospital transformed sepsis response using IntelliSep, leading to greater diagnostic clarity, smoother team communication, improved patient outcomes, and streamlined workflows. Finally, hear a real-world story about a Nurse Practitioner at St. Dominic's who survived sepsis, and how her experience reshaped her clinical practice.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Cytovale for this sponsored webinar.
Rhonda Collins, DNP, RN, FAAn
Chief Nursing Officer
Cytovale
Rhonda Collins, DNP, RN, FAAN, is the Chief Nursing Officer at Cytovale and a leader in healthcare innovation. A nurse for over 30 years, she co-founded the American Nurse Project to elevate nurses’ voices.
Previously, she served as Chief Nursing Officer at Vocera, improving clinical communication worldwide. She also held leadership roles at CareFusion, Masimo, and Fresenius Kabi, where she led a medical device through FDA clearance and U.S. launch.
A Fellow of the American Academy of Nursing, Dr. Collins holds degrees from Texas Tech University Health Sciences Center and the University of Texas. A published author and sought-after speaker, she focuses on nursing leadership, cognitive overload, and communication technology in healthcare.
Tracey Smithson, RN, MSN, NEA-BC
Chief Nursing Officer
St. Dominic’s Medical Center
Tracey Smithson, RN, MSN, NEA-BC, is an accomplished healthcare executive with over three decades of clinical and leadership experience. As Vice President and Chief Nursing Officer at St. Dominic’s Medical Center, she provides strategic and clinical oversight for a multi-campus system encompassing 5,000 staff and 565 beds, including a comprehensive stroke center, a level III trauma emergency department, and the Mississippi Heart & Vascular Institute.
Tracey has a proven track record of improving clinical outcomes, streamlining operations, and leading major accreditations and redesignations across multiple facilities. She is a sought-after speaker and thought leader, recognized as one of Dallas-Fort Worth’s Great 100 Nurses and a Leader of the Year at Medical City North Hills. Tracey serves on the board of the Mississippi Heart and Vascular Institute and remains an active voice in advancing nursing excellence and healthcare delivery across the Southeast.
Dan Woods, MSN, RN
Senior Director of Emergency Services and Hospital Throughput
St. Dominic’s Medical Center
Dan Woods, MSN, RN, is a dynamic healthcare executive with clinical roots and a decade of progressive leadership experience. As Senior Director of Emergency Services and Hospital Throughput for St. Dominic Health within Franciscan Missionaries of Our Lady Health System, he leads patient flow and acute care transfer strategies across a multi-hospital network serving thousands of patients across the Gulf South.
Dan has led enterprise initiatives including the development of centralized transfer and logistics centers, large-scale ED expansions, community crises, and EHR transitions, all aimed at improving throughput, resource utilization, and care delivery across the continuum. His work is grounded in data, frontline collaboration, and real-time operational responsiveness.
A frequent speaker on operational excellence, he has been honored as the Catholic Health Association’s Tomorrow’s Leader and one of Mississippi’s Emerging Leaders. Committed to developing future talent, Dan mentors through the ACHE mentoring program and serves on the board of the Greater Jackson Chamber of Commerce, helping shape the future of care delivery and workforce development.
-
Register for this if you plan to claim CE credits for 3+ podcast episodes.
Description:
This package includes the CE evaluations and CE credits for each individual podcast episode. You can register for the individual episode evaluations if you plan to complete fewer than three.
Forget everything you ever read in a textbook when it comes to antimicrobial resistance (AMR) and sepsis complications – because they rarely play by the rules. They evolve, adapt, and strike before it’s too late. While classic symptoms like fever, tachycardia, and hypotension are well known, the real challenge lies in recognizing the unexpected to reduce your mental list of those unknown, unknowns.
Hosted by Critical Care RN & CNS Author Nicole Kupchik, The Sepsis Spectrum is an exploration of real-world patient cases, expert insights, and clinical deep dives to unravel the most complex presentations facing modern medicine. Through gripping stories and in-depth interviews, Nicole examines diagnostic challenges, cutting-edge treatments, and the growing threat of AMR.
Designed for healthcare professionals at every level, The Sepsis Spectrum is about leaving you with more than compelling stories—it’s a vital resource in podcast form. Whether you’re at the bedside or in the classroom, you’ll finish each episode with practical, life-saving knowledge—and earn free CE Contact Hours for nurses along the way.
The fight against sepsis and AMR starts with recognition — because the most dangerous threats are the ones you don’t see coming.
Learning Objectives:
At the end of the series, the learner should be able to:
- Identify the public health threat posed by antimicrobial resistance (AMR) and describe the relationship between infection prevention, AMR, and sepsis;
- Assess the interconnections between humans, animals, and the environment in relation to AMR and sepsis;
- Apply recommendations for recognizing, diagnosing, and treating AMR and sepsis in outpatient and pre-hospital settings;
- Analyze the consequences of healthcare-acquired infections involving multi-drug-resistant organisms and discuss strategies for their prevention;
- Describe the importance of multi-disciplinary collaboration among infection prevention, antimicrobial stewardship, and sepsis teams in enhancing early detection, appropriate treatment, and improved outcomes in infectious disease management;
- Explore innovations in AMR and sepsis diagnostics and treatments, with a focus on how they aim to personalize patient care;
- Evaluate how quality improvement and patient safety practices address healthcare-acquired infections, multidrug-resistant organisms, and sepsis;
- Implement best practices for care coordination and transitions of care discharge planning, with an emphasis on AMR and antimicrobial stewardship in post-sepsis patient care;
- Consider specific care needs and best practices for managing AMR and sepsis in specialty populations, including pediatric, maternal, and immunocompromised patients.
Target audience:
All healthcare professionals and healthcare students including nurses, physicians, advanced practice providers, pharmacists, infectious disease and prevention specialists, scientists, and researchers, sepsis coordinators, sepsis data & quality professionals, healthcare executives and leadership, nursing and medical school deans & faculty, professional healthcare organizations, healthcare advocates, government, and industry.
-
Content provided by FIZE Medical (No CE credits offered)
Webinar Description:
Join top critical care experts in this FIZE Medical-sponsored webinar for a fresh look at managing unstable ICU patients using available biomarkers and real-time metrics. This webinar will cover the latest on sepsis, acute kidney injury (AKI), and hemodynamic management. Attendees will leave with a better understanding of how smarter data can drive faster, more targeted decisions when every second counts in the ICU.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by FIZE Medical for this sponsored webinar.
Joseph Carcillo, MD
Professor of Critical Care Medicine and Pediatrics
University of Pittsburgh, Department of Critical Care Medicine
Joseph Carcillo, MD, specializes in pediatric critical care medicine and pediatrics. He is certified by the American Board of Pediatrics and affiliated with UPMC Horizon, UPMC Mercy, UPMC Children's Hospital of Pittsburgh, UPMC Altoona, and UPMC Northwest. He completed his medical degree at George Washington University Medical Center, along with a residency and fellowship at Children's National Medical Center. He was previously Taskforce Chair of the ACCM Guidelines for Hemodynamic Support of Newborn and Pediatric Septic Shock, and a member of the Centers for Disease Control and Prevention (CDC) Taskforce for Definitions of Pediatric Sepsis.
Ravindra L. Mehta, MD, FACP, FRCP
Program Director - Associate Chair for Clinical Medicine, Department of Medicine
UC San Diego School of Medicine
Ravindra Mehta, MD, FACP, FRCP, is a Professor Emeritus of Medicine at the University of California San Diego where he directs the UCSD Master of Advanced Studies in Clinical Research program and is the site Principal Investigator of the NIH-funded UAB/UCSD O’Brien Center for AKI research. He chairs the annual International AKI and CRRT Conference in San Diego. Dr. Mehta is a founding member of the Acute Dialysis Quality Initiative (ADQI) and the Acute Kidney Injury Network (AKIN). His research has informed >span class="NormalTextRun SCXW217165272 BCX0"> development of the KDIGO guidelines for AKI. He has spearheaded several innovative multicenter studies on AKI including the International Society of Nephrology (ISN) AKI 0by25 project.
In 2008 Dr. Mehta was recognized by the American Nephrologists of Indian Origin and in March 2009 he was elected as a Fellow of the Royal College of Physicians in the UK. He received the ISN Bywaters Award for lifetime achievement in AKI in 2011 and in 2020 the ISN honored him by establishing a fellowship in AKI in his name.
He received the M.B.B.S. degree (1976) from the Government Medical School in Amritsar, India, and the M.D. (1979) and D.M. (1981) degrees from the Post Graduate Institute of Medical Education and Research in Chandigarh, India. He obtained his boards in Internal Medicine (1986) and Nephrology (1988) at the University of Rochester in Rochester New York. He has been on the faculty at UC San Diego since 1988.
-
This session explores the most severe forms of sepsis affecting pregnant and postpartum individuals in the U.S.
Description:
Date: May 14, 2025
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
Maternal Sepsis Week highlights the urgency of addressing perinatal sepsis, a leading cause of maternal morbidity and mortality. This session explores the most severe forms of sepsis affecting pregnant and postpartum individuals in the U.S., examining their connection to emerging infectious threats. Current treatment guidelines will be applied to critical care scenarios, assessing the effectiveness of different management strategies. The session also focuses on proactive approaches to early detection and intervention, particularly during disease outbreaks, to improve patient outcomes and reduce complications.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe the severe forms of sepsis affecting pregnant women in the US;
- Explain the relationship of severe forms of sepsis to rising endemic and pandemic diseases;
- Apply current treatment guidelines to manage cases of critical perinatal sepsis;
- Analyze the effectiveness of different treatment strategies for perinatal sepsis.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Jason Vaught, MD
Associate Professor of Gynecology and Obstetrics
Johns Hopkins University School of Medicine
Jason Vaught, MD, is an Associate Professor of Gynecology and Obstetrics, and Surgery at the Johns Hopkins Hospital where he serves as a maternal fetal medicine and critical care specialist. His research studies and clinical expertise include maternal critical illness, cardiac disease in pregnancy, hypertensive disorders of pregnancy, and placenta accreta spectrum.
He has been active in the care of both pregnant and non-pregnant patients within the COVID pandemic. He also serves as the Director of Labor and Delivery at Johns Hopkins Hospital.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hour.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
- Describe the severe forms of sepsis affecting pregnant women in the US;